AI assistant
SOLESENCE, INC. — Director's Dealing 2022
Jun 17, 2022
33563_dirs_2022-06-17_521bd8c4-d32c-42f2-837e-b199742f077d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NANOPHASE TECHNOLOGIES Corp (NANX)
CIK: 0000883107
Period of Report: 2022-06-13
Reporting Person: JANKOWSKI JESS (Director, President, CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-06-13 | Common Stock | M | 7800 | $0.30 | Acquired | 66800 | Direct |
| 2022-06-13 | Common Stock | S | 7800 | $3.00 | Disposed | 59000 | Direct |
| 2022-06-15 | Common Stock | M | 12485 | $0.30 | Acquired | 71485 | Direct |
| 2022-06-15 | Common Stock | S | 12485 | $3.00 | Disposed | 59000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-06-13 | Common Stock (right to purchase) | $0.30 | M | 7800 | Disposed | 2022-08-07 | Common Stock (63845) | Direct |
| 2022-06-15 | Common Stock (right to purchase) | $0.30 | M | 12485 | Disposed | 2022-08-07 | Common Stock (56045) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1000 | Indirect |
| Common Stock | 59000 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Common Stock (right to purchase) | $0.415 | 2023-02-14 | Common Stock (90000) | 90000 | Direct |
| Common Stock (right to purchase) | $0.52 | 2024-02-13 | Common Stock (90000) | 90000 | Direct |
| Common Stock (right to purchase) | $0.44 | 2025-02-18 | Common Stock (81000) | 81000 | Direct |
| Common Stock (right to purchase) | $0.42 | 2026-02-23 | Common Stock (69000) | 69000 | Direct |
| Common Stock (right to purchase) | $0.68 | 2027-02-21 | Common Stock (81000) | 81000 | Direct |
| Common Stock (right to purchase) | $0.82 | 2028-05-23 | Common Stock (90000) | 90000 | Direct |
| Common Stock (right to purchase) | $0.51 | 2029-05-22 | Common Stock (16500) | 16500 | Direct |
| Common Stock (right to purchase) | $0.45 | 2027-06-18 | Common Stock (90000) | 90000 | Direct |
| Common Stock (right to purchase) | $4.17 | 2028-12-28 | Common Stock (90000) | 90000 | Direct |
Footnotes
F1: This transaction was communicated to the reporting person on June 17th due to a clerical error.
F2: These options were set to expire on 08/07/2022. Under the Company's Policy on Insider Trading, all Nanophase employees will enter a blackout period on 06/25/2022, which will not end until three working days after the Company releases Q22022 earnings.
F3: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.
F4: Subject to certain restrictions, beginning on this date, options vest in three equal installments.
F5: Subject to certain restrictions, beginning on this date, the options vest in three equal annual installments.